is tirzepatide still on the fda shortage list reconsidering its decision to take off its drug The recent announcement that Tirzepatide

For more details, visit this article and this article

10.2337/dc10-2415 130 ZhengH.CaiL.RinamanL

Moreover, improvements in mood observed in some patients during GLP1 therapy could relate to secondary benefits, such as weight loss, reduced glycemic variability, or enhanced selfefficacy, rather than a direct neurochemical effect

Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method or add a barrier method of contraception for 4 weeks after initiation and for 4 weeks after each dose escalation with MOUNJARO [see Drug Interactions (7.2), Use in Specific Populations (8.3), and Clinical Pharmacology (12.3)]

Both weight loss from Wegovy and propranolol can lower blood pressure

10.2337/dc13-2760 143